Covaxin Phase 2/3 Trials In Children Till 18 To Begin In 10-12 Days
New Delhi: The Phase II/III clinical trials of Covaxin, indigenous COVID-19 vaccine, in the 2-18-year-olds will begin in the next 10-12 days, senior NITI Aayog member VK Paul announced Tuesday. The proposal was deliberated in Subject Expert Committee (SEC) (COVID-19) on May 11, the Health […]
National News